Results
1 -
10 of
18
(Click
here to explore results)
Macrocycles in Drug Discovery, CHAPTER 7 Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors: Inhibitor Design and Macrocyclization Strategies for HCV Protease and Related Targets . Wieslaw M. Kazmierski, Richard L. Jarvest, Jacob J. Plattner, Xianfeng Li
, 2015
, Pages 235-282
The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection . Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 9 Pharmacokinetics and Metabolism of Compounds that Mimic Enzyme Transition States . Iain Gardner, Chris Barber, Martin Howard, Aarti Sawant, Kenny Watson
, 2010
, Pages 390-459
Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 7 HCV NS3/4a Protease Inhibitors: Simeprevir (TMC‐435350), Vaniprevir (MK‐7009) and MK‐5172 . John A. McCauley, Michael T. Rudd, Nigel J. Liverton
, 2013
, Pages 189-247
Catalytic Aerobic Oxidations, CHAPTER 6 Bio-catalyzed Aerobic Oxidation Reactions . J. Vilím, T. Knaus, F. G. Mutti
, 2020
, Pages 131-180
Amino Acids, Peptides and Proteins: Volume 38, Peptide and protein based pharmaceuticals . Gábor Mezo
, 2014
, Volume 38
, Pages 203-252
The Handbook of Medicinal Chemistry: Principles and Practice, CHAPTER 20 Lead Generation . Mark Furber, Frank Narjes, John Steele
, 2015
, Pages 505-528
Fragment-Based Drug Discovery, CHAPTER 7 Fragment-Based Discovery of Allosteric Ligands . Steven Howard
, 2015
, Pages 153-176
Biocatalysis: An Industrial Perspective, CHAPTER 2 Biocatalysis – A Greener Alternative in Synthetic Chemistry . Madhuresh Kumar Sethi, Purbita Chakraborty, Rohit Shukla
, 2018
, Pages 44-76
Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534